Blueprint Medicines Corp Buy Hold or Sell Recommendation
| BPMCDelisted Stock | USD 129.46 0.11 0.09% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Blueprint Medicines Corp is 'Not Rated'. Macroaxis provides Blueprint Medicines buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BPMC positions.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. In addition, we conduct extensive research on individual companies such as Blueprint and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Blueprint Medicines Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Blueprint |
Execute Blueprint Medicines Buy or Sell Advice
The Blueprint recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Blueprint Medicines Corp. Macroaxis does not own or have any residual interests in Blueprint Medicines Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Blueprint Medicines' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Blueprint Medicines Trading Alerts and Improvement Suggestions
| Blueprint Medicines is not yet fully synchronised with the market data | |
| Blueprint Medicines appears to be risky and price may revert if volatility continues | |
| Blueprint Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 508.82 M. Net Loss for the year was (67.09 M) with profit before overhead, payroll, taxes, and interest of 542.35 M. | |
| Blueprint Medicines Corp currently holds about 853.11 M in cash with (192.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.28. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
Blueprint Medicines Returns Distribution Density
The distribution of Blueprint Medicines' historical returns is an attempt to chart the uncertainty of Blueprint Medicines' future price movements. The chart of the probability distribution of Blueprint Medicines daily returns describes the distribution of returns around its average expected value. We use Blueprint Medicines Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Blueprint Medicines returns is essential to provide solid investment advice for Blueprint Medicines.
| Mean Return | 0.59 | Value At Risk | -1.66 | Potential Upside | 3.23 | Standard Deviation | 4.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Blueprint Medicines historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 1051 shares by Carter Percy H. of Blueprint Medicines at 128.25 subject to Rule 16b-3 [view details]
Blueprint Medicines Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Blueprint . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Blueprint Medicines Buy or Sell Advice
When is the right time to buy or sell Blueprint Medicines Corp? Buying financial instruments such as Blueprint Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Blueprint Medicines in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small & Mid Caps ETFs Thematic Idea Now
Small & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small & Mid Caps ETFs theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Blueprint Stock
If you are still planning to invest in Blueprint Medicines Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Blueprint Medicines' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |